Evidence map›Paper›PMID 40862805›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3).

Samar Attieh, Leonard Angka, Christine Lafontaine, Cynthia Mitchell, Julie Carignan, Carolina Ilkow, Simon Turcotte, Rachel Goodwin, Rebecca C Auer, Carmen G Loiselle

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samar AttiehDepartment of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Leonard AngkaCancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.ORCID 0000-0001-8324-6054
Christine LafontaineCancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Cynthia MitchellPatient Representative, Winnipeg, MB, Canada.
Julie CarignanPatient Representative, Quebec City, QC, Canada.
Carolina IlkowCancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Simon TurcotteDépartement de Chirurgie, Service de Transplantation Hépatique et de Chirurgie Hépatopancréatobiliaire, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0C1, Canada.
Rachel GoodwinDivision of Medical Oncology, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Rebecca C AuerDepartment of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Carmen G LoiselleGerald Bronfman Department of Oncology and Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2M7, Canada.ORCID 0000-0002-1981-2645

Funding

Canadian Cancer Society/ Canadian Institutes of Health Research Breakthrough Team Grant 707709
6 · The paper itself

Abstract

Person-centered navigation (PCN) in healthcare refers to a proactive collaboration among professionals, researchers, patients, and their families to guide individuals toward timely access to screening, treatment, follow-up, and psychosocial support. PCN-which includes professional, peer, and virtual guidance, is particularly crucial for rare cancers, where affected individuals face uncertainty, limited support, financial strain, and difficulties accessing relevant information, testing, and other services. The Canadian Cholangiocarcinoma Collaborative (C3) prioritizes PCN implementation to address these challenges in the context of Biliary Tract Cancers (BTCs). C3 uses a virtual PCN model and staffs a "C3 Research Navigator" who provides clinical and research navigation such as personalized guidance and support, facilitating access to molecular testing, clinical trials, and case reviews through national multidisciplinary rounds. C3 also supports a national network of BTC experts, a patient research registry, and advocacy activities. C3's implementation strategies include co-design, timely delivery of support, and optimal outcomes across its many initiatives. Future priorities include expanding the C3 network, enhancing user engagement, and further integrating its innovative approach into routine care.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaPatient NavigationRare DiseasesCanadaHumansPatient-Centered Careadvocacybiliary tract cancercancer navigationcholangiocarcinomahoperare cancer

Identifiers

PMID40862805
PMCPMC12384775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.